Innovate UK x ATMP Flemingsberg: Collaborations, Inspiration, and Networking

At the beginning of the year, we had the privilege of welcoming a delegation from England, with representatives from Innovate UK and eleven ATMP (Advanced Therapy Medicinal Products) companies. This marks the beginning of a significant partnership with great potential to ultimately cure diseases that were previously incurable.

ATMP Flemingsberg
It was an intense morning that began with a presentation of the new initiative ATMP Flemingsberg. Flemingsberg is more than just a location; it’s a hub where expertise, innovation, and collaboration seamlessly come together. This unique environment is characterized by its close proximity, the growing city, and of course the Karolinska ATMP center, which brings together world-leading research, the hospital and cutting-edge research facilities.

– The visit from Innovate UK was very successful. We and the companies and research infrastructures within ATMP in Flemingsberg had a unique opportunity to meet companies from England and listen to interesting business ideas and discuss future collaborations. The event also shows the fantastic ecosystem in the field that exists in Flemingsberg, which our visitors also testify to! Now we from the foundation are following up with our companies how we can take this further and see how we can create a structure for long-term cooperation with Innovate UK, says Johnny Högberg CEO of Flemingsberg Science Foundation.

An Ecosystem for Innovation
Flemingsberg-based companies XNK Therapeutics and Biomedrex took the stage to share their journeys, emphasizing how the vibrant atmosphere of Flemingsberg played a crucial role in their success stories. The synergy between the hospital, academia, and research institutes at the heart of Flemingsberg creates an exceptional ecosystem for innovation.

The day also included a pitching session that provided a platform for both British and local companies to showcase their visions. This not only fostered a deeper understanding of each other’s capabilities but also paved the way for potential collaborations in the future. This exchange laid the groundwork for future partnerships, knowledge exchange, and breakthroughs in the field of advanced therapies. We look forward to taking the next step in this partnership.

Cluster Engine Flemingsberg – ERDF Project for Growth in Life Science

Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.

BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development

As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.

BIO-Europe – A Conference for Future Medical Innovations

BIO-Europe is Europe’s largest partnering conference for the biotechnology, pharmaceutical, and life science industries. The conference serves as a meeting place where companies, researchers, investors, and other stakeholders in the industry can network, establish collaborations, and discuss business opportunities. The event is held annually in various European cities. This year, BIO-Europe took place in Stockholm from November 4th to 6th, where discussions included advanced cell and gene therapies as the medicine of the future.

Previous 181920 Next